Summary

The Australian electrocardiograph (ECG) market is at the intersection of modern technology and comprehensive healthcare, showing the country's dedication to improved medical diagnostics and patient-centred care. The Australian ECG industry has evolved significantly in recent years, characterised by a dynamic blend of innovation, tight regulatory standards, and an increasing emphasis on preventative healthcare. This market segment serves a varied range of healthcare settings, from hospitals and clinics to growing trends in telemedicine and home-based care, with a focus on precision, accessibility, and the integration of digital health technologies. The Therapeutic Goods Administration (TGA) regulates ECG products in Australia. According to the TGA, ECG equipment sold in Australia must be dependable and secure. In order to commercialise ECG equipment in Australia, manufacturers must get a TGA conformity assessment certificate. This certificate attests to the equipment's compliance with all relevant safety and efficiency criteria. Before their products can be sold in Australia, companies must register them with the Australian Register of Therapeutic Goods (ARTG). The Australian government finances the development of medical equipment in addition to numerous sorts of medical research and development. The Medical Study Future Fund (MRFF) provides funding for healthcare-related research and innovation, including the development of novel medical equipment. The enormous geographical terrain of Australia includes distant and rural areas where access to specialised healthcare services can be difficult. In these domains, ECG technology, particularly portable and remote monitoring options, is critical. The use of ECG devices that offer telemedicine and remote monitoring improves access to cardiac diagnoses and care for people living in rural areas. In Australia, coordination between public and private healthcare facilities promotes the use of ECG technology. Both industries invest in cutting-edge medical technology, such as ECG gadgets, to ensure universal availability and access to cutting-edge cardiac diagnostic tools across the healthcare spectrum.

According to the research report "Australia Electrocardiograph (ECG) Market Overview, 2028," published by Bonafide Research, the Australia Electrocardiograph (ECG) market is projected to reach market size of more than USD 180 Million by 2028. Miniaturisation and wearable technology advancements have resulted in the creation of portable and wearable ECG equipment. These devices are convenient since they allow patients to have continuous ECG monitoring outside of clinical settings. Mobility and convenience of use respond to the growing trend of remote patient monitoring and promote Australian telemedicine programmes. The focus on improving healthcare access in remote and rural areas in Australia has accelerated the development and implementation of telemedicine systems. ECG equipment linked to telemedicine platforms provides real-time transmission of cardiac data to healthcare providers, allowing for remote monitoring and consultation. This technique addresses the access gap to specialised cardiac treatment in remote areas. ECG devices in Australia are rapidly being created with advanced connection features that allow for seamless interaction with electronic health record (EHR) systems and other healthcare platforms. Interoperability across various devices and systems simplifies data interchange, maintaining complete patient records, and supporting efficient workflows for healthcare practitioners. In Australia, the development of ECG devices capable of personalised monitoring and tailored therapies is gaining traction. These devices analyse individual cardiac patterns using advanced algorithms, enabling more personalised treatment plans and actions. Furthermore, they provide continuous remote monitoring, allowing patients to actively participate in the management of their cardiac health.

Based on product market is categorised into resting electrocardiograph (ECG), stress electrocardiograph (ECG), holter monitors, event recorders and others. Resting electrocardiograph (ECG) product is playing crucial role in development of Australia Electrocardiograph (ECG) market. Resting ECGs are regularly performed in hospitals, clinics, and primary care institutions throughout Australia. The extensive usage of these devices guarantees that cardiac diagnostics are available to a large range of patients, allowing for early identification and intervention for heart problems. Resting ECGs are performed in a standardised and non-invasive manner, making them widely accepted by both healthcare professionals and patients. This standardised procedure improves the reliability and consistency of cardiac examinations, allowing healthcare providers to make accurate diagnoses based on the heart's recorded electrical activity. Based on end user segment market is bifurcated into hospitals & clinics, home settings & ambulatory surgical centers (ASCs) and others. Home settings & ambulatory surgical centers (ASCs) segment is expected to grow at significant pace in Australia Electrocardiograph (ECG) market. The desire for patient convenience, cost-effectiveness, and developments in portable medical technologies are driving an increasing trend towards home-based healthcare solutions in Australia. Home ECG devices allow patients to do self-monitoring and remote ECG recordings, contributing to the trend of managing heart health outside of traditional healthcare settings. ASCs offer outpatient operations and diagnostic services, including cardiac assessments. The use of portable and ambulatory ECG machines in these centres allows for more efficient and thorough diagnostic assessments for patients receiving cardiac examinations outside of traditional hospital settings. The convenience and accessibility provided by ASCs contribute to the increased use of ECGs at these facilities.

Considered in this report:
• Geography: Australia
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Australia Electrocardiograph (ECG) market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product:
• Resting Electrocardiograph (ECG)
• Stress Electrocardiograph (ECG)
• Holter Monitors
• Event Recorders
• Others

By End User:
• Hospitals & Clinics
• Home Settings & Ambulatory Surgical Centers (ASCs)
• Others

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Electrocardiograph (ECG) industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents